Doriano Fabbro is the Chief Scientific Officer at Swiss Rockets AG, a renowned drug discovery and kinase expert with over 30 years of experience split between academia and the pharmaceutical industry. He earned his PhD from the University of Basel and previously led oncology drug discovery at Novartis, contributing to several major approved drugs.
Colleagues have described him as genuinely supportive and helpful, praising his extensive experience and constructive criticism which fosters cooperation within and between research groups.
He played a pivotal role in the development of paradigm-shifting cancer therapies, including the globally recognized drugs Gleevec, Tasigna, and Afinitor.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.